Outcomes of a Quality Improvement Program to Reduce Hospital-acquired Pressure Ulcers in Pediatric Patients

Vita Boyar1

  • 1Department of Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, NY; and Hofstra North Shore-LIJ School of Medicine, Hempstead, NY.

Ostomy/Wound Management
|November 10, 2018
PubMed

Insights

A quality improvement program successfully reduced hospital-acquired pressure injuries (PIs) in pediatric patients. Implementing a debrief protocol and prevention bundle decreased PIs by 40% and fostered a stronger safety culture.

Area of Science:

  • Pediatric Healthcare Quality Improvement
  • Patient Safety Research
  • Hospital-Acquired Conditions

Background:

  • Hospital-acquired pressure injuries (PIs) pose a significant challenge in pediatric care settings.
  • A comprehensive prevention strategy is crucial to mitigate the incidence and severity of pediatric pressure ulcers (PUs)/PIs.

Purpose of the Study:

  • To develop and implement a debrief protocol for pediatric pressure ulcers (PUs)/PIs.
  • To evaluate compliance with a comprehensive prevention bundle aimed at reducing PU/PI incidence and severity.
  • To decrease the overall incidence and severity of pediatric pressure ulcers (PUs)/PIs in a children's hospital.

Main Methods:

  • A quality improvement program was initiated within a national patient safety network.
  • A PU Hospital Acquired Conditions (HAC) team developed a debrief tool, discussion guide, educational strategies, and a prevention bundle.
  • PU incidence data were collected annually from 2014 to 2017, with debriefings occurring within 24-48 hours of PU occurrence.

Main Results:

  • Compliance with the prevention bundle elements ranged from 88% to 94%.
  • The incidence of PUs/PIs decreased by 30% from 2014 to 2016 and by 40% in 2017.
  • Device-related PIs constituted 65% of cases, with respiratory devices being the most common cause; significant reductions were observed in respiratory device-related PIs across various units.

Conclusions:

  • The integrated approach of debriefing, education, and a prevention bundle effectively reduced hospital-acquired PIs in pediatric patients.
  • The program successfully propagated a culture of safety within the pediatric healthcare setting.
  • The findings highlight the importance of targeted interventions for device-related PIs in vulnerable pediatric populations.

Related Concept Videos

Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296